Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: KEGG:D01170 (
ZnO
)
13,684
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The synthesis of hybrid materials possessing zinc oxide nanoparticles encapsulated in core-shell polymer particles having poly(methyl methacrylate) core and chitosan shell (PMMA-CS/
ZnO
) was carried out via an emulsifier-free emulsion polymerization. The
ZnO
nanoparticles modified by 3-(trimethoxysilyl)propyl methacrylate (TPMZnO) were first prepared before being charged to the polymerization system. The effects of polymerization time (from 2 h to 6 h) and the amount of TPMZnO added (0.018 g, 0.020 g, and 0.030 g) were studied. It was found that the polymerization time of 5 h yielded colloidally stable hybrid latex with%
MMA
conversion up to 90%. Moreover, the increase in the amount of TPMZnO resulted in a decrease in%
MMA
conversion from 90% to 80%. It was also found from TGA analysis that the amount of TPMZnO added affected the percentage of TPMZnO encapsulation. PMMA-CS/
ZnO
particles with the size ranging from 173 to 245 nm were observed by TEM. In addition, the PMMA-CS/
ZnO
hybrid latexes possessed high positive charges in the range of 40-51 mV. The electrochemical property of the electrodes fabricated from PMMA-CS/
ZnO
nanoparticles was illustrated by cyclic voltammetry.
...
PMID:Synthesis of zinc oxide-encapsulated poly(methyl methacrylate)-chitosan core-shell hybrid particles and their electrochemical property. 2221 39
The photocatalytic removal of arsenite [As(III)] and monomethylarsonic acid [
MMA
(V)] was investigated in the presence of UV light (350 nm) and aqueous suspensions of
ZnO
synthesized by the sol-gel technique. Photocatalytic removal of these potent arsenic compounds results in the effective and rapid mineralization to less toxic inorganic arsenate [As(V)]. The effect of
ZnO
loading and solution pH on the treatment efficiency of the UV/
ZnO
photocatalytic process was evaluated. The optimal conditions for the removal of 5 mg L(-1) [As(III)] and [
MMA
(V)] aqueous solutions were observed at catalyst loadings of 0.25 and 0.50 g L(-1) with solution pH values of 7 and 8, respectively. Under these conditions, the activity of photocatalyst sol-gel
ZnO
was compared with TiO2 Degussa P25 and commercial
ZnO
catalyst. The results demonstrate that the high adsorption capacity of
ZnO
synthesized by sol-gel gives enhanced removal of arsenic species from water samples, indicating that this catalyst is a promising material for treatment of arsenic contaminated groundwater.
...
PMID:Photocatalytical removal of inorganic and organic arsenic species from aqueous solution using zinc oxide semiconductor. 2306 94
Antibacterial polymer surfaces were designed using
ZnO
nanoparticles as a bactericide. Mineral encapsulated nanoparticles were grafted onto activated polymer surfaces through their shells. Polypropylene (PP) surfaces were treated using an innovative process coupling core-shell technology and plasma grafting, well-known techniques commonly used to obtain active surfaces for biomedical applications. First,
ZnO
nanoparticles were encapsulated by (co)polymers: poly(acrylic acid) (PAA) or a poly(methyl methacrylate-co-methacrylic acid) copolymer [P(
MMA
-MA)]. Second, PP substrates were activated using plasma treatment. Finally, plasma-treated surfaces were immersed in solutions containing the encapsulated nanoparticles dispersed in an organic solvent and allowed to graft onto it. The presence of nanoparticles on the substrates was demonstrated using Fourier-Transform Infrared Spectroscopy (FTIR) analysis, Scanning Electron Microspcopy (SEM)/Energy-Dispersive X-ray (EDX), and Atomic Force Microscopy (AFM) studies. Indeed, the
ZnO
-functionalized substrates exhibited an antibacterial response in Escherichia coli adhesion tests. Moreover, this study revealed that, surprisingly, native
ZnO
nanoparticles without any previous functionalization could be directly grafted onto polymeric surfaces through plasma activation. The antibacterial activity of the resulting sample was shown to be comparable to that of the other samples.
...
PMID:Synthesis of antibacterial surfaces by plasma grafting of zinc oxide based nanocomposites onto polypropylene. 2362
The influence of
ZnO
nanoparticles on the thermal degradation behavior of poly(methyl methacrylate) (PMMA) was tested using thermoanalytical techniques. The studied materials were investigated using TG, DTA, EGA, XRD, SEM and TEM. The
ZnO
nanoparticles were synthesized via precipitation by adding LiOH into Zn2+ water/ethylene glycol solutions. The
ZnO
-PMMA nanocomposites were prepared by adding the appropriate amount of
ZnO
into
MMA
and subsequent
MMA
radical polymerization. According to the experimental results and model-free isoconversional activation energy calculations, the addition of
ZnO
into PMMA played a double role. The
ZnO
concentrations up to 0.15% stabilized the composite by shifting the degradation interval toward higher temperatures and increasing the apparent activation energy relative to pure PMMA. At higher concentrations, the catalytic effect of
ZnO
started to prevail and was reflected in the lower temperature intervals of intense PMMA degradation and lower apparent activation energy. The addition of
ZnO
generally did not change the nature of the PMMA decomposition process.
...
PMID:Effect of ZnO on the Thermal Degradation Behavior of Poly(Methyl Methacrylate) Nanocomposites. 2764 Mar 80